190 related articles for article (PubMed ID: 30930056)
1. Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.
Roake CM; Chen L; Chakravarthy AL; Ferrell JE; Raffa GD; Artandi SE
Mol Cell; 2019 May; 74(4):688-700.e3. PubMed ID: 30930056
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
Fok WC; Shukla S; Vessoni AT; Brenner KA; Parker R; Sturgeon CM; Batista LFZ
Blood; 2019 Mar; 133(12):1308-1312. PubMed ID: 30728146
[TBL] [Abstract][Full Text] [Related]
4. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Moon DH; Segal M; Boyraz B; Guinan E; Hofmann I; Cahan P; Tai AK; Agarwal S
Nat Genet; 2015 Dec; 47(12):1482-8. PubMed ID: 26482878
[TBL] [Abstract][Full Text] [Related]
5. Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.
Boyraz B; Moon DH; Segal M; Muosieyiri MZ; Aykanat A; Tai AK; Cahan P; Agarwal S
J Clin Invest; 2016 Sep; 126(9):3377-82. PubMed ID: 27482890
[TBL] [Abstract][Full Text] [Related]
6. Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.
Shukla S; Jeong HC; Sturgeon CM; Parker R; Batista LFZ
Blood Adv; 2020 Jun; 4(12):2717-2722. PubMed ID: 32559291
[TBL] [Abstract][Full Text] [Related]
7. Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.
Dejene EA; Li Y; Showkatian Z; Ling H; Seto E
J Biol Chem; 2020 Jul; 295(30):10255-10270. PubMed ID: 32457045
[TBL] [Abstract][Full Text] [Related]
8. PARN Modulates Y RNA Stability and Its 3'-End Formation.
Shukla S; Parker R
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760775
[TBL] [Abstract][Full Text] [Related]
9. Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs.
Fu D; Collins K
Mol Cell; 2003 May; 11(5):1361-72. PubMed ID: 12769858
[TBL] [Abstract][Full Text] [Related]
10. TOE1 acts as a 3' exonuclease for telomerase RNA and regulates telomere maintenance.
Deng T; Huang Y; Weng K; Lin S; Li Y; Shi G; Chen Y; Huang J; Liu D; Ma W; Songyang Z
Nucleic Acids Res; 2019 Jan; 47(1):391-405. PubMed ID: 30371886
[TBL] [Abstract][Full Text] [Related]
11. The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Shukla S; Bjerke GA; Muhlrad D; Yi R; Parker R
Mol Cell; 2019 Mar; 73(6):1204-1216.e4. PubMed ID: 30770239
[TBL] [Abstract][Full Text] [Related]
12. Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP.
Trahan C; Dragon F
RNA; 2009 Feb; 15(2):235-43. PubMed ID: 19095616
[TBL] [Abstract][Full Text] [Related]
13. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
Cerone MA; Ward RJ; Londoño-Vallejo JA; Autexier C
Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
[TBL] [Abstract][Full Text] [Related]
14. Telomere biology disorders: time for moving towards the clinic?
Batista LFZ; Dokal I; Parker R
Trends Mol Med; 2022 Oct; 28(10):882-891. PubMed ID: 36057525
[TBL] [Abstract][Full Text] [Related]
15. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
MacNeil DE; Lambert-Lanteigne P; Autexier C
Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
[TBL] [Abstract][Full Text] [Related]
16. The H/ACA complex disrupts triplex in hTR precursor to permit processing by RRP6 and PARN.
Tseng CK; Wang HF; Schroeder MR; Baumann P
Nat Commun; 2018 Dec; 9(1):5430. PubMed ID: 30575725
[TBL] [Abstract][Full Text] [Related]
17. Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.
Ashbridge B; Orte A; Yeoman JA; Kirwan M; Vulliamy T; Dokal I; Klenerman D; Balasubramanian S
Biochemistry; 2009 Nov; 48(46):10858-65. PubMed ID: 19835419
[TBL] [Abstract][Full Text] [Related]
18. A Polyadenylation-Dependent 3' End Maturation Pathway Is Required for the Synthesis of the Human Telomerase RNA.
Nguyen D; Grenier St-Sauveur V; Bergeron D; Dupuis-Sandoval F; Scott MS; Bachand F
Cell Rep; 2015 Dec; 13(10):2244-57. PubMed ID: 26628368
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation.
Ren X; Gavory G; Li H; Ying L; Klenerman D; Balasubramanian S
Nucleic Acids Res; 2003 Nov; 31(22):6509-15. PubMed ID: 14602909
[TBL] [Abstract][Full Text] [Related]
20. Human Telomerase RNA Processing and Quality Control.
Tseng CK; Wang HF; Burns AM; Schroeder MR; Gaspari M; Baumann P
Cell Rep; 2015 Dec; 13(10):2232-43. PubMed ID: 26628367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
